Andrea Havasi

Andrea Havasi

Auto-generated profile, based on publicly available information

Andrea Havasi

Department of Medicine, Renal Section, Boston Medical Center, Evans Biomedical Research Center, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Kidney International
Verified
Journal Article
Open access
PDF file
AHAndrea Havasi
Andrea Havasi
SBSteven C Borkan
Steven C Borkan
Improved mechanistic understanding of renal cell death in acute kidney injury (AKI) has generated new therapeutic targets. Clearly, the classic lesion of acute tubular necrosis is not adequate to describe the consequences of renal ischemia, nephrotoxin exposure, or sepsis on glomerular filtration rate. Experimental evidence supports a pathogenic role for apoptosis in AKI. Interestingly, proximal tubule epithelial cells are highly susceptible to apoptosis, and injury at this site contributes to organ failure. During apoptosis, well-orchestrated events converge at the mitochondrion, the organelle that integrates life and death signals generated by the BCL2 (B-cell lymphoma 2) protein family. Death requires the ‘perfect storm’ for outer mitochondrial membrane injury to release its cellular ‘executioners’. The complexity of this process affords new targets for effective interventions, both before and after renal insults. Inhibiting apoptosis appears to be critical, because circulating factors released by the injured kidney induce apoptosis and inflammation in distant organs including the heart, lung, liver, and brain, potentially contributing to the high morbidity and mortality associated with AKI. Manipulation of known stress kinases upstream of mitochondrial injury, induction of endogenous, anti-apoptotic proteins, and improved understanding of the timing and consequences of renal cell apoptosis will inevitably improve the outcome of human AKI.

1 May 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AHAndrea Havasi
Andrea Havasi
ZLZhijian Li
Zhijian Li
ZWZhiyong Wang
Zhiyong Wang
JMJody L. Martin
Jody L. Martin
VBVenugopal Botla
Venugopal Botla
SBSteven C. Borkan
Steven C. Borkan
Hsp27 inhibits mitochondrial injury and apoptosis in both normal and cancer cells by an unknown mechanism. To test the hypothesis that Hsp27 decreases apoptosis by inhibiting Bax, Hsp27 expression was manipulated in renal epithelial cells before transient metabolic stress, an insult that activates Bax, induces mitochondrial injury, and causes apoptosis. Compared with control, enhanced Hsp27 expression inhibited conformational Bax activation, oligomerization, and translocation to mitochondria, reduced the leakage of both cytochrome c and apoptosis-inducing factor, and significantly improved cell survival by >50% after stress. In contrast, Hsp27 down-regulation using RNA-mediated interference promoted Bax activation, increased Bax translocation, and reduced cell survival after stress. Immunoprecipitation did not detect Hsp27-Bax interaction before, during, or after stress, suggesting that Hsp27 indirectly inhibits Bax. During stress, Hsp27 expression prevented the inactivation of Akt, a pro-survival kinase, and increased the interaction between Akt and Bax, an Akt substrate. In contrast, Hsp27 RNA-mediated interference promoted Akt inactivation during stress. Hsp27 up- or down-regulation markedly altered the activity of phosphatidylinositol 3-kinase (PI3-kinase), a major regulator of Akt. Furthermore, distinct PI3-kinase inhibitors completely abrogated the protective effect of Hsp27 expression on Akt activation, Bax inactivation, and cell survival. These data show that Hsp27 antagonizes Bax-mediated mitochondrial injury and apoptosis by promoting Akt activation via a PI3-kinase-dependent mechanism.

1 October 2013 in Kidney International
Verified
Journal Article
Open access
PDF file
MCMarta Christov
Marta Christov
SWSushrut S. Waikar
Sushrut S. Waikar
RPRenata C. Pereira
Renata C. Pereira
AHAndrea Havasi
Andrea Havasi
DLDavid E. Leaf
David E. Leaf
HJHarald Jüppner
Harald Jüppner
Emerging evidence suggests that fibroblast growth factor 23 (FGF23) levels are elevated in patients with acute kidney injury (AKI). In order to determine how early this increase occurs, we used a murine folic acid–induced nephropathy model and found that plasma FGF23 levels increased significantly from baseline already after 1 <!----> h of AKI, with an 18-fold increase at 24 <!----> h. Similar elevations of FGF23 levels were found when AKI was induced in mice with osteocyte-specific parathyroid hormone receptor ablation or the global deletion of parathyroid hormone or the vitamin D receptor, indicating that the increase in FGF23 was independent of parathyroid hormone and vitamin D signaling. Furthermore, FGF23 levels increased to a similar extent in wild-type mice maintained on normal or phosphate-depleted diets prior to induction of AKI, indicating that the marked FGF23 elevation is at least partially independent of dietary phosphate. Bone production of FGF23 was significantly increased in AKI. The half-life of intravenously administered recombinant FGF23 was only modestly increased. Consistent with the mouse data, plasma FGF23 levels rose 15.9-fold by 24 <!----> h following cardiac surgery in patients who developed AKI. The levels were significantly higher than in those without postoperative AKI. Thus, circulating FGF23 levels rise rapidly during AKI in rodents and humans. In mice, this increase is independent of established modulators of FGF23 secretion.

1 September 2009 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
ZWZhiyong Wang
Zhiyong Wang
AHAndrea Havasi
Andrea Havasi
JGJonathan M. Gall
Jonathan M. Gall
HMHaiping Mao
Haiping Mao
JSJohn H. Schwartz
John H. Schwartz
SBSteven C. Borkan
Steven C. Borkan
Ischemia activates Bax, a proapoptotic BCL2 protein, as well as the prosurvival β-catenin/Wnt signaling pathway. To test the hypothesis that β-catenin/Wnt signaling regulates Bax-mediated apoptosis after induction of metabolic stress, which occurs during renal ischemia, we infected immortalized and primary proximal tubular epithelial cells with adenovirus to express either constitutively active or dominant negative β-catenin constructs. Constitutively active β-catenin significantly decreased apoptosis and improved cell survival after metabolic stress. Furthermore, active β-catenin decreased Bax activation, oligomerization, and translocation to mitochondria, and reduced both organelle membrane injury and apoptosis. Dominant negative β-catenin had the opposite effects. Because Akt regulates Bax, we examined the effects of the β-catenin mutants on Akt expression and activation. Constitutively active β-catenin increased Akt-1 expression and activation before and after stress, and treatment with a phosphatidylinositol-3 kinase inhibitor antagonized the protective effects of β-catenin on Akt activation, Bax inhibition, and cell survival. In addition, β-catenin significantly increased the rate of phosphorylation at Bax serine184, an Akt-specific target. Taken together, these results suggest that β-catenin/Wnt signaling promotes survival of renal epithelial cells after metabolic stress, in part by inhibiting Bax in a phosphatidylinositol-3 kinase/Akt-dependent manner.

1 December 2012 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
DBDaniela I. Beiderbeck
Daniela I. Beiderbeck
SRStefan O. Reber
Stefan O. Reber
AHAndrea Havasi
Andrea Havasi
RBRemco Bredewold
Remco Bredewold
AVAlexa H. Veenema
Alexa H. Veenema
INInga D. Neumann
Inga D. Neumann

1 February 2010 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
ZWZhiyong Wang
Zhiyong Wang
AHAndrea Havasi
Andrea Havasi
JGJonathan Gall
Jonathan Gall
RBRamon Bonegio
Ramon Bonegio
ZLZhijian Li
Zhijian Li
SBSteven C. Borkan
Steven C. Borkan
The mechanism by which the serine-threonine kinase glycogen synthase kinase-3β (GSK3β) affects survival of renal epithelial cells after acute stress is unknown. Using in vitro and in vivo models, we tested the hypothesis that GSK3β promotes Bax-mediated apoptosis, contributing to tubular injury and organ dysfunction after acute renal ischemia. Exposure of renal epithelial cells to metabolic stress activated GSK3β, Bax, and caspase 3 and induced apoptosis. Expression of a constitutively active GSK3β mutant activated Bax and decreased cell survival after metabolic stress. In contrast, pharmacologic inhibition (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione [TDZD-8]) or RNA interference–mediated knockdown of GSK3β promoted cell survival. Furthermore, RNA interference–mediated knockdown of Bax abrogated the cell death induced by constitutively active GSK3β. In a cell-free assay, TDZD-8 inhibited the phosphorylation of a peptide containing the Bax serine163 site targeted by stress-activated GSK3β. In rats, TDZD-8 inhibited ischemia-induced activation of GSK3β, Bax, and caspase 3; ameliorated tubular and epithelial cell damage; and significantly protected renal function. Taken together, GSK3β-mediated Bax activation induces apoptosis and tubular damage that contribute to acute ischemic kidney injury.